Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-05

Clinical Trial Update: Amisulpride in Schizophrenic Acute Phase Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update showing completion of a study evaluating amisulpride in the acute phase of schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solian (amisulpride)

Snippet

Sponsor: Sanofi | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED